(Q35058133)

6 August 2017

1 reference

title

Review of lamotrigine and its clinical applications in epilepsy (English)

1 reference

6 August 2017

1 reference

Hyunmi Choi

1

1 reference

6 August 2017

Martha J Morrell

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

243-251

1 reference

Liver function and folate epilepsy in the rat.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Effects of lamotrigine on electrically induced afterdischarge duration in anaesthetised rat, dog, and marmoset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Lamotrigine for the treatment of epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: an open, prospective, long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.243

21 January 2018

Identifiers

DOI

10.1517/14656566.4.2.243

1 reference

6 August 2017

1 reference